Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF/ICSI treatments

Reproductive BioMedicine Online

Volumn 16, Issue 5, 2008, Pages 632-639

  Ho, Chi Hong ^a   Chen, Shee Uan ^b   Peng, Fu Shiang ^c   Chang, Chih Yuan ^b   Lien, Yih Ron ^b   Yang, Yu Shih ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

IVF; Long GnRH agonist protocol; Short GnRH agonist protocol

Indexed keywords

BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT GONADOTROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOWN REGULATION; DRUG COST; DRUG RESPONSE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVULATION INDUCTION; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT DURATION;

EID: 44249090030     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60476-2     Document Type: Article

References (40)

1. U Acharya J Small J Randall Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program Fertility and Sterility 57 1992 815 818
2. H Al-Inany AM Abou-Setta M Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review Reproductive BioMedicine Online 14 2007 640 649
3. H Al-Inany MA Aboulghar RT Mansour Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin Gynecological Endocrinology 20 2005 161 169
4. AN Andersen P Devroey JC Arce Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial Human Reproduction 21 2006 3217 3227
5. Z Ben-Rafael S Lipitz D Bider Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels Fertility and Sterility 55 1991 272 275
6. D Bodri V Vernaeve JJ Guillen Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial Human Reproduction 21 2006 2246 2251
7. RA Cabrera L Stadtmauer JF Mayer Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone Fertility and Sterility 83 2005 42 48
8. KW Cheon HK Byun KM Yang Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques Journal of Reproductive Medicine 49 2004 733 738
9. DW Cramer DR Powers SP Oskowitz Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates Fertility and Sterility 72 1999 83 89
10. S Daya Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles Cochrane Database of Systemic Reviews 2000 CD001299-
11. G De Placido C Alviggi A Perino Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial Human Reproduction 20 2005 390 396
12. C Dietterich JH Check JK Choe Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer Fertility and Sterility 77 2002 781 786
13. P Drakakis D Loutradis K Kallianidis Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET European Journal of Obstetrics, Gynecology, and Reproductive Biology 121 2005 77 80
14. T Eldar-Geva E Zylber-Haran R Babayof Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation Reproductive BioMedicine Online 14 2007 148 154
15. M Filicori C Flamigni GE Cognigni Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis Fertility and Sterility 65 1996 387 393
16. R Fischer Understanding the role of LH: myths and facts Reproductive BioMedicine Online 15 2007 468 477
17. SG Hillier Gonadotropic control of ovarian follicular growth and development Molecular and Cellular Endocrinology 179 2001 39 46
18. O Hovatta I Cooke Cost-effective approaches to in vitro fertilization: Means to improve access International Journal of Gynaecology and Obstetrics 94 2006 287 291
19. EG Hughes DM Fedorkow S Daya The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials Fertility and Sterility 58 1992 888 896
20. P Humaidan M Bungum L Bungum Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study Reproductive BioMedicine Online 8 2004 635 643
21. IP Kosmas EM Kolibianakis P Devroey Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review Human Reproduction 19 2004 2446 2453
22. R Lahoud M Al-Jefout J Tyler A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates Human Reproduction 21 2006 2645 2649
23. SY Liu JL Han XD Peng Effect of midfollicular luteinizing hormone levels on ovarian response and pregnancy outcome in patients undergoing in vitro fertilization in a short-term protocol Fertility and Sterility 83 2005 1043 1046
24. D Loutradis K Stefanidis P Drakakis Comparison between ‘short' and ‘long’ protocols in an ICSI programme European Journal of Obstetrics, Gynecology, and Reproductive Biology 120 2005 69 72
25. R Marrs D Meldrum S Muasher Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment Reproductive BioMedicine Online 8 2004 175 182
26. R Palermo Differential actions of FSH and LH during folliculogenesis Reproductive BioMedicine Online 15 2007 326 337
27. N Prapas Y Prapas Y Panagiotidis GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study Human Reproduction 20 2005 1516 1520
28. CV Rao Multiple novel roles of luteinizing hormone Fertility and Sterility 76 2001 1097 1100
29. BH Rashidi M Sadeghi M Jafarabadi Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern European Journal of Obstetrics, Gynecology, and Reproductive Biology 120 2005 179 184
30. G Ruvolo L Bosco A Pane Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures Fertility and Sterility 87 2007 542 546
31. GA San Roman ES Surrey HL Judd A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization Fertility and Sterility 58 1992 744 749
32. RL Schild C Knobloch C Dorn Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow Fertility and Sterility 75 2001 361 366
33. M Shemesh Actions of gonadotrophins on the uterus Reproduction 121 2001 835 842
34. J Smitz R Ron-El BC Tarlatzis The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres Human Reproduction 7 Suppl. 1 1992 49 66
35. SL Tan C Kingsland S Campbell The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization Fertility and Sterility 57 1992 810 814
36. B Tarlatzis E Tavmergen M Szamatowicz The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study Human Reproduction 21 2006 90 94
37. BC Tarlatzis G Pados J Bontis Ovarian stimulation with buserelin/HMG/HCG: prospective randomized study of short versus long protocol Human Reproduction 8 1993 807 812
38. J Tesarik C Mendoza Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence Human Reproduction 17 2002 3129 3137
39. LG Westergaard K Erb SB Laursen Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study Fertility and Sterility 76 2001 543 549
40. R Yoeli J Ashkenazi R Orvieto Significance of increased endometrial thickness in assisted reproduction technology treatments Journal of Assisted Reproduction and Genetics 21 2004 285 289